By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hikma Pharmaceuticals 

13 Hanover Square

London    W1S 1HL  United Kingdom
Phone: 44-0-20-7399-2760 Fax: 44-0-20-7399-2761



Company News
Hikma (HIK.L) Interim Results 8/19/2015 9:42:45 AM
Hikma (HIK.L) Snags Boehringer Ingelheim's U.S. Generics Biz for $2.65 Billion 7/28/2015 5:46:08 AM
Hikma (HIK.L) Rumored to Be Bidding $2.2B for Boehringer Ingelheim's Roxane Laboratories, As Mallinckrodt (MNK), Perrigo (PRGO) Circle 6/30/2015 6:06:29 AM
Hikma Pharmaceuticals (HIK.L) Founder And Honorary Life President Samih Darwazah Passes Away 5/18/2015 11:32:35 AM
Hikma Pharmaceuticals (HIK.L) Release: AGM Trading Update 5/14/2015 11:47:39 AM
Hikma Pharmaceuticals (HIK.L) Launches Caffeine Citrate Injection, Commercialising The First Of The Bedford Products 5/12/2015 9:22:01 AM
Hikma Pharmaceuticals (HIK.L) Delivers An Excellent Performance In 2014 With Group Revenue Growth Of 9% And Basic EPS Up 30% 3/11/2015 10:33:22 AM
Hikma Pharmaceuticals (HIK.L) To Launch Colchicine 0.6mg Capsules 1/12/2015 6:59:59 AM
Hikma Pharmaceuticals (HIK.L) Release: Interim Management Statement 11/6/2014 12:29:46 PM
Hikma Pharmaceuticals (HIK.L) Falls On FDA Warning For Portugal Plant 10/24/2014 5:53:54 AM